For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | -1,516 | |||
| Asset impairment | 0 | |||
| General and administrative | 3,948 | |||
| Total operating expenses | 2,432 | |||
| Loss from operations | -2,432 | |||
| Other income | 0 | |||
| Interest income, net | 511 | |||
| Total other income | 511 | |||
| Net loss | -1,921 | |||
| Basic EPS | -0.39 | |||
| Diluted EPS | -0.39 | |||
| Basic Average Shares | 4,908,164 | |||
| Diluted Average Shares | 4,908,164 | |||
MUSTANG BIO, INC. (MBIO)
MUSTANG BIO, INC. (MBIO)